Location History:
- München, DE (2002)
- Munich, DE (2005)
- Erlangen, DE (2010 - 2011)
Company Filing History:
2 out of 8 
1 out of 11 
1 out of 143 
Years Active: 2002-2011
Title: **Michael Hensel: Innovator in Vaccine Development**
Introduction
Michael Hensel, an accomplished inventor based in Erlangen, Germany, has made significant contributions to the field of vaccine development. With a total of four patents to his name, Hensel is recognized for his innovative approaches to creating more effective and safer vaccines. His work focuses on leveraging genetic engineering techniques to enhance vaccine efficacy.
Latest Patents
Hensel's latest patents include the invention of attenuated Salmonella SP12 mutants as antigen carriers. This innovative technology pertains to the development of vaccines involving an attenuated gram-negative cell that comprises the SPI2 gene locus. Notably, at least one gene of the SPI2 locus is inactivated, which results in a reduction of virulence compared to the wild type of the cell. This invention provides a unique carrier for the presentation of an antigen to a host. The carrier, being the attenuated gram-negative cell, possesses at least one heterologous nucleic acid molecule that encodes for the antigen, and is capable of expressing or facilitating the expression of this nucleic acid molecule in a target cell.
Career Highlights
Throughout his career, Michael Hensel has been associated with notable companies such as Emergent Product Development UK Limited and Microscience Limited. These experiences have enriched his knowledge and expertise in the field of biotechnology, particularly in vaccine research and development.
Collaborations
Hensel has also collaborated with esteemed colleagues, including David William Holden and Jacqueline Elizabeth Shea, who have contributed to various aspects of his research and innovation projects. Their teamwork has been instrumental in advancing the frontier of vaccine technology.
Conclusion
Michael Hensel’s work exemplifies the spirit of innovation in biomedical sciences. His patents represent not only technological advancements but also pave the way for future developments in vaccine efficacy and safety. With his continued contributions, Hensel stands out as a key figure in the quest to enhance public health through effective vaccination strategies.